Clinical Trial Update: Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating acalabrutinib in combination with rituximab for elderly patients with untreated mantle cell lymphoma is ongoing (ACTIVE_NOT_RECRUITIN…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Acalabrutinib (acalabrutinib)
• Rituximab (rituximab)

Snippet

Sponsor: Nordic Lymphoma Group | Conditions: MCL, Mantle Cell Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING